ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.51
1.35%
US Tech 100
20,214.80
0.44%
S&P 500
5,963.18
0.78%
US Dollar vs CAD
1.39658
-0.03%
Bitcoin
98,517.35
4.41%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Novavax Inc (NVAX)

  7. Novavax Inc (NVAX) News

NVAX

Novavax (NVAX)

Novavax Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NVAX
DateTimeSourceHeadlineSymbolCompany
11/15/20246:47AMPR Newswire (US)Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)NASDAQ:NVAXNovavax Inc
11/13/20243:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
11/13/20247:00AMPR Newswire (US)Novavax to Participate in Jefferies London Healthcare ConferenceNASDAQ:NVAXNovavax Inc
11/12/20243:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
11/12/202410:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
11/12/20247:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
11/12/20247:02AMPR Newswire (US)Novavax Reports Third Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
11/11/20247:30AMPR Newswire (US)U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 TrialNASDAQ:NVAXNovavax Inc
11/05/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
11/04/20243:30PMPR Newswire (US)Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024NASDAQ:NVAXNovavax Inc
11/04/20245:00AMPR Newswire (US)Åsa Manelius Named Managing Director of Novavax AB SiteNASDAQ:NVAXNovavax Inc
10/16/20247:14AMPR Newswire (US)Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 TrialNASDAQ:NVAXNovavax Inc
10/16/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
10/09/20246:00AMPR Newswire (US)Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EUNASDAQ:NVAXNovavax Inc
09/25/20247:00AMPR Newswire (US)Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & DevelopmentNASDAQ:NVAXNovavax Inc
09/18/20243:08PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NVAXNovavax Inc
09/13/20248:25AMPR Newswire (US)Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.NASDAQ:NVAXNovavax Inc
09/04/20248:25AMPR Newswire (US)Novavax to Participate in Upcoming September ConferencesNASDAQ:NVAXNovavax Inc
08/30/20243:19PMPR Newswire (US)Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.NASDAQ:NVAXNovavax Inc
08/30/20242:46PMPR Newswire (US)Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.NASDAQ:NVAXNovavax Inc
08/21/20243:47PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
08/20/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
08/08/20243:15PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NVAXNovavax Inc
08/08/20247:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
08/08/20247:02AMPR Newswire (US)Novavax Reports Second Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
08/08/20246:37AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
08/08/20244:55AMIH Market NewsU.S. Index Futures Drop, Signaling Ongoing Market Volatility; Oil Prices StallNASDAQ:NVAXNovavax Inc
08/01/20248:25AMPR Newswire (US)Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024NASDAQ:NVAXNovavax Inc
07/31/20244:55AMIH Market NewsASML Rises 7% on Export Waiver; Intel Plans Layoffs, HSBC $3B Buyback Announced, and MoreNASDAQ:NVAXNovavax Inc
07/02/20247:30AMPR Newswire (Canada)Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 VaccineNASDAQ:NVAXNovavax Inc
 Showing the most relevant articles for your search:NASDAQ:NVAX

Your Recent History

USOTC
AXXTF
Axiata Group BHD (PK)
NASDAQI
OB30680L
Optimal Blue 30Yr Conf F...
BIT
I06546
Banca Imi
BIT
P1JTE4
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved